about
Current medical treatment of estrogen receptor-positive breast cancerSuccessful outcome after combined chemotherapeutic and surgical management in a case of esophageal cancer with breast and brain relapse.Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: a single institutional experienceAdjuvant Treatment of Early Breast Cancer in the Elderly.Advances in the Treatment of Triple-negative Early Breast Cancer.Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer.Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.Tamoxifen induced severe hypertriglyceridemia in a male patient with breast carcinoma.Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery.Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).Cisplatin-gemcitabine as palliative chemotherapy in advanced squamous vulvar carcinoma: report of two cases.Fulminant liver failure in a patient affected by polycystic liver disease and liver metastases from breast carcinoma.Ultrasonic dissection system technology in breast cancer: a case-control study in a large cohort of patients requiring axillary dissection.Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.Comment on "repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results": will there be clinical implications in the future?Chemo/tomotherapy stereotactic body radiation therapy (chemo/SBRT) for the salvage treatment of esophageal carcinoma following trimodality therapy: a case report.Analysis of epidermal growth factor receptor (EGFR) status in endometrial stromal sarcoma.Primary small cell bladder carcinomaSmall cell lung cancer in a young patient with osteopetrosisWeekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages?Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancerBRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal MelanomasIn situ malignant melanoma on nevus spilus in an elderly patient
P50
Q26795751-79F2F8BF-9AA6-40F9-AF8F-438E963CBD57Q33869588-B1191626-C2C6-414C-846F-C71F8BC28997Q35781556-638A5032-892E-4B8A-B155-C9A1D4AE1149Q38633239-87D4571B-44A5-42CF-922E-4A8CBA5B3173Q38633246-62C018D8-C981-49CE-BC28-0D4AC325DBF8Q38801271-FD2452CE-C034-471F-9F58-C22211B85449Q39454037-0CB8475C-52B8-48F9-9D01-473894513049Q43290794-2DE0751C-C0A2-4583-B04F-9547F559B37EQ43837760-C681B3C8-BF8E-409A-8608-530B2C9DE5DEQ44056096-19534221-8504-4643-9647-5DC6D1FB1CF6Q45342567-27B072CE-F34D-4273-9E39-705CAFDDDA79Q46895052-FB3B9A8A-6629-403E-B126-836CDD453E14Q46912435-AD45E0D5-F361-4B3F-8DAB-889B2E12B4B0Q47218550-6938CB8B-56FA-4745-A117-DFF4791953E0Q47409192-CE402FCE-575E-4193-BE5F-FC8E8EB1C22FQ51443498-2CD3C253-DD61-4A5C-A314-4D2552835FBFQ53128779-A23CD09C-F65C-4A72-A3BD-795CD45247F4Q54456562-84A42EE7-D536-4DC6-B5E6-AA245C946CF4Q57647333-3F86A183-39B5-4CAA-BEC9-A4692FCD684DQ79681832-ADC08B08-2BDB-4EC2-A23A-233E1681618BQ84514196-5EB9D219-E7F0-450F-BE0F-ECC4FA93FCD3Q86272531-AC71D534-665E-4013-BC21-6595D0897EF9Q90460722-72142FED-807E-40AE-8C65-4216B679FA5CQ95566691-5F9A0013-5D3C-4651-A5E3-7C2E9B10EB24
P50
description
researcher ORCID ID = 0000-0002-9872-9523
@en
wetenschapper
@nl
name
Davide Adriano Santeufemia
@ast
Davide Adriano Santeufemia
@en
Davide Adriano Santeufemia
@es
Davide Adriano Santeufemia
@nl
type
label
Davide Adriano Santeufemia
@ast
Davide Adriano Santeufemia
@en
Davide Adriano Santeufemia
@es
Davide Adriano Santeufemia
@nl
prefLabel
Davide Adriano Santeufemia
@ast
Davide Adriano Santeufemia
@en
Davide Adriano Santeufemia
@es
Davide Adriano Santeufemia
@nl
P106
P21
P31
P496
0000-0002-9872-9523